| Literature DB >> 30823503 |
Janusz J Petkowski1, William Bains2, Sara Seager3,4,5.
Abstract
Phosphorous-pan> class="Chemical">containing molecules are essential constituents of all living cells. While the phosphate functional group is very common in small molecule natural products, nucleic acids, and as chemical modification in protein and peptides, phosphorous can form P⁻N (phosphoramidate), P⁻S (phosphorothioate), and P⁻C (e.g., phosphonate and phosphinate) linkages. While rare, these moieties play critical roles in many processes and in all forms of life. In this review we thoroughly categorize P⁻N, P⁻S, and P⁻C natural organophosphorus compounds. Information on biological source, biological activity, and biosynthesis is included, if known. This review also summarizes the role of phosphorylation on unusual amino acids in proteins (N- and S-phosphorylation) and reviews the natural phosphorothioate (P⁻S) and phosphoramidate (P⁻N) modifications of DNA and nucleotides with an emphasis on their role in the metabolism of the cell. We challenge the commonly held notion that nonphosphate organophosphorus functional groups are an oddity of biochemistry, with no central role in the metabolism of the cell. We postulate that the extent of utilization of some phosphorus groups by life, especially those containing P⁻N bonds, is likely severely underestimated and has been largely overlooked, mainly due to the technological limitations in their detection and analysis.Entities:
Keywords: N-phosphorylation; P–C bond; P–N bond; P–S bond; S-phosphorylation; phosphinate; phosphine; phosphonate; phosphoramidate; phosphorothioate
Mesh:
Substances:
Year: 2019 PMID: 30823503 PMCID: PMC6429109 DOI: 10.3390/molecules24050866
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Phosphoramidates (bold font) are traditionally divided into two classes of compounds. Compounds of class I are characterized by the presence of terminal P–OH group (e.g., phosphagen—N-phosphocreatine). Compounds of class II are characterized by the presence of the accessible terminal P–NH2 group (e.g., adenosine 5′-phosphoramidate).
Figure 2Biosynthetic pathways for fosfazinomycins A (2) and B (3) as proposed in recent studies by [10,11,12,15]. Putative steps are denoted by dashed lines.
Figure 3(A) The initial transformation in the biosynthetic pathway for the phosphoramidate modification of the sugar residues in the bacterial capsular polysaccharides (CPS) proceeds via direct phosphorylation of the amide nitrogen of l-glutamine with ATP by a specific L-glutamine kinase (EC 2.7.3.13) to form N-phospho-l-glutamine (16). (B) Compound 16 is a precursor for P–N bond-containing sugar residues (17, 18) of the CPS and it is proposed to undergo a series of transformations before the formation of the final CPS product (with the formation of inorganic phosphoramidate (33) and 3′-Phospho-5′-cytidine diphosphoramidate (34) as P–N bond-containing intermediates) [46,47,48,49]. Enzymes from Campylobacter jejuni CPS biosynthetic gene cluster with the known function in the CPS biosynthetic pathway are marked in bold font.
Natural occurrence and biochemical and structural characterization of phosphagens and phosphagen kinases.
| Phosphagen | Natural Occurrence and Biochemical and Structural Characterization of the Phosphagen Kinases | ||||
|---|---|---|---|---|---|
| Domain, Kingdom (or other) | Phylum | Class | Species * | Reference | |
|
|
|
|
| [ | |
|
|
| [ | |||
|
|
| [ | |||
|
|
| [ | |||
|
|
| [ | |||
|
|
| [ | |||
|
|
|
| [ | ||
|
|
| [ | |||
|
|
| [ | |||
|
|
|
| [ | ||
|
|
|
| [ | ||
|
|
|
| [ | ||
|
|
|
| [ | ||
|
|
| [ | |||
|
|
| [ | |||
|
|
|
| [ | ||
|
|
| [ | |||
|
|
|
| [ | ||
|
|
|
|
| [ | |
|
|
|
|
| [ | |
|
|
|
|
| [ | |
|
|
|
|
| [ | |
|
|
| [ | |||
|
|
|
|
| [ | |
|
|
| [ | |||
|
|
| [ | |||
|
|
| [ | |||
|
|
| [ | |||
|
|
| [ | |||
|
|
| [ | |||
|
|
|
| [ | ||
|
|
|
| [ | ||
|
|
|
| [ | ||
|
|
|
| [ | ||
|
|
|
|
| [ | |
|
|
| [ | |||
|
|
|
| [ | ||
|
|
|
|
| [ | |
|
|
|
|
| [ | |
|
|
|
|
| [ | |
|
|
|
| [ | ||
|
|
|
|
| [ | |
|
|
|
|
| [ | |
|
|
|
|
| [ | |
|
|
| [ | |||
|
|
|
|
| [ | |
|
|
|
|
| [ | |
* Species listed in bold font are known to produce more than one type of phosphagen. It is not unheard of for many organisms to utilize more than one type of phosphagen. For example, sea urchin Strongylocentrotus purpuratus produces both N-phosphoarginine (19) and N-phosphocreatine (20). Another example is a multiphosphagen system in Namalycastis sp., where cytoplasmic creatine and glycocyamine kinases work together and complement the mitochondrial creatine kinase. The resulting high levels of N-phosphocreatine (20) and N-phosphoglycocyamine (23) allow for a very quick response to sudden high energy requirements [226].
Scheme 1The last step of the phosphagens’ biosynthetic pathway.
Figure 4In vitro synthesis of AMPN compound by adenylyl transferase (EC 2.7.7.51) enzyme.